Ora Biomedical, Inc.
Ben Blue's work experience begins in 2015 as a Laboratory Technician at the University of Oregon, where they worked from June 2015 to September 2017. In 2022, they became the Chief Technology Officer at Ora Biomedical, Inc.
Ben Blue attended the University of Oregon from 2010 to 2015, where they obtained a Bachelor of Science in Biochemistry. Ben then went on to enroll at the University of Washington - School of Medicine from 2017 to 2022, specializing in Pathology/Experimental Pathology. No degree information is provided for their time at the University of Washington.
This person is not in the org chart
This person is not in any teams
Ora Biomedical, Inc.
Ora Biomedical, Inc. is a new pharmaceutical company launched out of the Kaeberlein Lab at the University of Washington. We built a high-throughput small molecule discovery platform to identify longevity interventions, including natural products, pharmaceuticals, and small molecule combinations at a previously unimagined scale. The foundation ofour platform is the WormBot-AI, a robotic system coupled with AI-powered analytics to perform phenotype-based screens in live animals. The WormBot-AI is robust, stable, scalable, and already in use identifying novel interventions and aging targets. Ora Biomedical holds the exclusive commercial use rights to the WormBot platform and AI software.